Financial results - OCULARCARE SRL

Financial Summary - Ocularcare Srl
Unique identification code: 33897191
Registration number: J40/14461/2014
Nace: 8622
Sales - Ron
749.808
Net Profit - Ron
162.272
Employee
6
The most important financial indicators for the company Ocularcare Srl - Unique Identification Number 33897191: sales in 2023 was 749.808 euro, registering a net profit of 162.272 euro and having an average number of 6 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Ocularcare Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - 4.539 44.769 125.047 348.142 424.152 372.289 493.439 584.893 749.808
Total Income - EUR - 4.539 44.769 125.083 348.201 424.159 375.171 493.478 592.836 765.006
Total Expenses - EUR - 4.232 15.807 89.359 215.329 289.618 259.174 299.286 436.382 584.743
Gross Profit/Loss - EUR - 306 28.962 35.724 132.872 134.540 115.996 194.191 156.454 180.263
Net Profit/Loss - EUR - 174 27.619 34.052 129.390 130.299 112.739 189.848 151.477 162.272
Employees - 0 0 3 4 5 5 4 5 6
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 28.6%, from 584.893 euro in the year 2022, to 749.808 euro in 2023. The Net Profit increased by 11.254 euro, from 151.477 euro in 2022, to 162.272 in the last year.

Check the financial reports for the company - Ocularcare Srl

Rating financiar

Financial Rating -
Ocularcare Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Ocularcare Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Ocularcare Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Ocularcare Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Ocularcare Srl - CUI 33897191

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - 29.962 67.885 131.267 513.215 519.663 480.377 468.573 1.561.309 1.714.566
Current Assets - 3.862 2.485 5.179 46.319 114.576 147.186 127.861 128.057 102.166
Inventories - 1.462 244 236 477 228 223 219 1.108 1.090
Receivables - 0 19 167 7.391 11.717 14.823 23.118 18.375 29.953
Cash - 2.400 2.221 4.776 38.451 102.632 132.139 104.525 108.574 71.123
Shareholders Funds - 219 27.836 61.422 189.685 316.310 359.478 522.203 675.300 835.525
Social Capital - 45 45 48 47 46 45 44 45 44
Debts - 33.605 42.533 75.024 369.850 317.966 268.602 75.087 1.016.689 984.000
Income in Advance - 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 102.166 euro in 2023 which includes Inventories of 1.090 euro, Receivables of 29.953 euro and cash availability of 71.123 euro.
The company's Equity was valued at 835.525 euro, while total Liabilities amounted to 984.000 euro. Equity increased by 162.272 euro, from 675.300 euro in 2022, to 835.525 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Ocularcare Srl

Comments - Ocularcare Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.